Yehuda Handelsman:尽管目前尚无指南的明确推荐,但有些数据的确表明,包括西格列汀在内的DPP-4抑制剂对肾脏有一定的积极影响。 《国际糖尿病》:随着DPP-4抑制剂循证证据的不断增加和积累,请谈谈未来即将修改的中华医学会糖尿病学分会(CDS...
ADA热评丨纪立农+Yehuda Handelsman:TECOS再掀热议:更多后续结果发布http://t.cn/Ro7LSwV
One of the best ways to increase compliance when treating diabetes is to ensure patients fully understand the importance of treatment, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America. However, this can be diffi...
Alan J. Garber, MD, PhD, FACE1; Lawrence Blonde, MD, FACP, FACE2; Zachary T. Bloomgarden, MD, MACE3; Yehuda Handelsman, MD, FACP, FACE4;Objective: To review available data on the efficacy and safety of bromocriptine-QR (BQR) and to consider its role in the management of Type 2 ...